Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Renal tubular cell spliced X-box binding protein 1 (Xbp1s) has a unique role in sepsis-induced acute kidney injury and inflammation.

Ferrè S, Deng Y, Huen SC, Lu CY, Scherer PE, Igarashi P, Moe OW.

Kidney Int. 2019 Aug 1. pii: S0085-2538(19)30775-6. doi: 10.1016/j.kint.2019.06.023. [Epub ahead of print]

PMID:
31601454
2.

Functional and Neuroprotective Role of Striatal Adenosine A2A Receptor Heterotetramers.

Ferré S, Ciruela F.

J Caffeine Adenosine Res. 2019 Sep 1;9(3):89-97. doi: 10.1089/caff.2019.0008. Epub 2019 Sep 17. Review.

3.

HgTe Nanocrystals for SWIR Detection and Their Integration up to the Focal Plane Array.

Chu A, Martinez B, Ferré S, Noguier V, Gréboval C, Livache C, Qu J, Prado Y, Casaretto N, Goubet N, Cruguel H, Dudy L, Silly MG, Vincent G, Lhuillier E.

ACS Appl Mater Interfaces. 2019 Sep 11;11(36):33116-33123. doi: 10.1021/acsami.9b09954. Epub 2019 Aug 30.

PMID:
31426628
4.

Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport.

Ferré S, Quiroz C, Rea W, Guitart X, García-Borreguero D.

Adv Pharmacol. 2019;84:3-19. doi: 10.1016/bs.apha.2018.12.005. Epub 2019 Jan 18.

PMID:
31229176
5.

Francisella tularensis: FupA mutation contributes to fluoroquinolone resistance by increasing vesicle secretion and biofilm formation.

Siebert C, Lindgren H, Ferré S, Villers C, Boisset S, Perard J, Sjöstedt A, Maurin M, Brochier-Armanet C, Couté Y, Renesto P.

Emerg Microbes Infect. 2019;8(1):808-822. doi: 10.1080/22221751.2019.1615848.

6.

The Adenosine Hypothesis of Restless Legs Syndrome.

Ferré S.

J Caffeine Adenosine Res. 2019 Mar 1;9(1):1-3. doi: 10.1089/caff.2019.0001. Epub 2019 Mar 14. No abstract available.

PMID:
30944909
7.

Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens.

Guitart X, Moreno E, Rea W, Sánchez-Soto M, Cai NS, Quiroz C, Kumar V, Bourque L, Cortés A, Canela EI, Bishop C, Newman AH, Casadó V, Ferré S.

Mol Neurobiol. 2019 Oct;56(10):6756-6769. doi: 10.1007/s12035-019-1564-8. Epub 2019 Mar 27.

PMID:
30919214
8.

Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Cai NS, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED, Guitart X, Rea W, Lam S, Moreno E, Casadó-Anguera V, Greenblatt AD, Jacobson AE, Rice KC, Casadó V, Newman AH, Winkelman JW, Michaelides M, Weintraub E, Volkow ND, Belcher AM, Ferré S.

J Clin Invest. 2019 Mar 26;129(7):2730-2744. doi: 10.1172/JCI126912.

9.

Low serum magnesium is associated with faster decline in kidney function: the Dallas Heart Study experience.

Ferrè S, Li X, Adams-Huet B, Maalouf NM, Sakhaee K, Toto RD, Moe OW, Neyra JA.

J Investig Med. 2019 Aug;67(6):987-994. doi: 10.1136/jim-2018-000966. Epub 2019 Mar 2.

10.

Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.

Steingruber M, Keller L, Socher E, Ferre S, Hesse AM, Couté Y, Hahn F, Büscher N, Plachter B, Sticht H, Marschall M.

J Biol Chem. 2019 Apr 12;294(15):6188-6203. doi: 10.1074/jbc.RA118.007049. Epub 2019 Feb 19.

PMID:
30782840
11.

Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.

Wei J, Kishton RJ, Angel M, Conn CS, Dalla-Venezia N, Marcel V, Vincent A, Catez F, Ferré S, Ayadi L, Marchand V, Dersh D, Gibbs JS, Ivanov IP, Fridlyand N, Couté Y, Diaz JJ, Qian SB, Staudt LM, Restifo NP, Yewdell JW.

Mol Cell. 2019 Mar 21;73(6):1162-1173.e5. doi: 10.1016/j.molcel.2018.12.020. Epub 2019 Jan 31.

PMID:
30712990
12.

New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders.

Ferré S, Díaz-Ríos M, Salamone JD, Prediger RD.

J Caffeine Adenosine Res. 2018 Dec 1;8(4):121-131. doi: 10.1089/caff.2018.0017. Epub 2018 Dec 7. Review.

13.

Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.

Casadó-Anguera V, Moreno E, Mallol J, Ferré S, Canela EI, Cortés A, Casadó V.

Pharmacol Res. 2019 Jan;139:337-347. doi: 10.1016/j.phrs.2018.11.032. Epub 2018 Nov 22.

PMID:
30472462
14.

Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant.

Sánchez-Soto M, Yano H, Cai NS, Casadó-Anguera V, Moreno E, Casadó V, Ferré S.

Mol Neurobiol. 2019 Jul;56(7):4778-4785. doi: 10.1007/s12035-018-1413-1. Epub 2018 Nov 1.

PMID:
30387076
15.

Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.

Pulido D, Casadó-Anguera V, Pérez-Benito L, Moreno E, Cordomí A, López L, Cortés A, Ferré S, Pardo L, Casadó V, Royo M.

J Med Chem. 2018 Oct 25;61(20):9335-9346. doi: 10.1021/acs.jmedchem.8b01249. Epub 2018 Oct 11.

PMID:
30257092
16.

Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas.

Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, Schwarcz R, Justinova Z.

Mol Neurobiol. 2019 May;56(5):3563-3575. doi: 10.1007/s12035-018-1319-y. Epub 2018 Aug 27.

PMID:
30151725
17.

New Insights into the Neurobiology of Restless Legs Syndrome.

Ferré S, García-Borreguero D, Allen RP, Earley CJ.

Neuroscientist. 2019 Apr;25(2):113-125. doi: 10.1177/1073858418791763. Epub 2018 Jul 26. Review.

PMID:
30047288
18.

Evolution of gene dosage on the Z-chromosome of schistosome parasites.

Picard MAL, Cosseau C, Ferré S, Quack T, Grevelding CG, Couté Y, Vicoso B.

Elife. 2018 Jul 25;7. pii: e35684. doi: 10.7554/eLife.35684.

19.

The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease.

Blum D, Chern Y, Domenici MR, Buée L, Lin CY, Rea W, Ferré S, Popoli P.

J Caffeine Adenosine Res. 2018 Jun 1;8(2):43-58. doi: 10.1089/caff.2018.0006. Review.

20.

Luciferase complementation based-detection of G-protein-coupled receptor activity.

Yano H, Cai NS, Javitch JA, Ferré S.

Biotechniques. 2018 Jul;65(1):9-14. doi: 10.2144/btn-2018-0039.

21.

New insights into the role of HNF-1β in kidney (patho)physiology.

Ferrè S, Igarashi P.

Pediatr Nephrol. 2019 Aug;34(8):1325-1335. doi: 10.1007/s00467-018-3990-7. Epub 2018 Jul 1. Review.

PMID:
29961928
22.

Fronto-striatal effective connectivity of working memory in adults with cannabis use disorder.

Ma L, Steinberg JL, Bjork JM, Keyser-Marcus L, Vassileva J, Zhu M, Ganapathy V, Wang Q, Boone EL, Ferré S, Bickel WK, Gerard Moeller F.

Psychiatry Res Neuroimaging. 2018 Aug 30;278:21-34. doi: 10.1016/j.pscychresns.2018.05.010. Epub 2018 Jun 8.

PMID:
29957349
23.

Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia.

Lanza K, Meadows SM, Chambers NE, Nuss E, Deak MM, Ferré S, Bishop C.

Neuropharmacology. 2018 Aug;138:304-314. doi: 10.1016/j.neuropharm.2018.06.024. Epub 2018 Jun 21.

PMID:
29936243
24.

Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Rivera-Oliver M, Moreno E, Álvarez-Bagnarol Y, Ayala-Santiago C, Cruz-Reyes N, Molina-Castro GC, Clemens S, Canela EI, Ferré S, Casadó V, Díaz-Ríos M.

Mol Neurobiol. 2019 Feb;56(2):797-811. doi: 10.1007/s12035-018-1120-y. Epub 2018 May 24.

PMID:
29797183
25.

Identifying language impairment in bilingual children in France and in Germany.

Tuller L, Hamann C, Chilla S, Ferré S, Morin E, Prevost P, Dos Santos C, Abed Ibrahim L, Zebib R.

Int J Lang Commun Disord. 2018 Jul;53(4):888-904. doi: 10.1111/1460-6984.12397. Epub 2018 May 23.

PMID:
29790243
26.

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase.

Ferré S, Bonaventura J, Zhu W, Hatcher-Solis C, Taura J, Quiroz C, Cai NS, Moreno E, Casadó-Anguera V, Kravitz AV, Thompson KR, Tomasi DG, Navarro G, Cordomí A, Pardo L, Lluís C, Dessauer CW, Volkow ND, Casadó V, Ciruela F, Logothetis DE, Zwilling D.

Front Pharmacol. 2018 Apr 9;9:243. doi: 10.3389/fphar.2018.00243. eCollection 2018.

27.

Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis.

Garcia-Borreguero D, Guitart X, Garcia Malo C, Cano-Pumarega I, Granizo JJ, Ferré S.

Sleep Med. 2018 May;45:94-97. doi: 10.1016/j.sleep.2018.02.002. Epub 2018 Feb 24.

PMID:
29680437
28.

Effect of urine pH and magnesium on calcium oxalate saturation.

Ferrè S, Grange JS, Adams-Huet Ms B, Moe OW, Maalouf NM.

Magnes Res. 2017 Nov 1;30(4):107-119. doi: 10.1684/mrh.2018.0429.

PMID:
29637896
29.

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase.

Navarro G, Cordomí A, Casadó-Anguera V, Moreno E, Cai NS, Cortés A, Canela EI, Dessauer CW, Casadó V, Pardo L, Lluís C, Ferré S.

Nat Commun. 2018 Mar 28;9(1):1242. doi: 10.1038/s41467-018-03522-3.

30.

Adenosine A2A-dopamine D2 receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics.

Fernandez-Duenas V, Ferré S, Ciruela F.

Neural Regen Res. 2018 Feb;13(2):241-243. doi: 10.4103/1673-5374.226388. No abstract available.

31.

α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Sánchez-Soto M, Casadó-Anguera V, Yano H, Bender BJ, Cai NS, Moreno E, Canela EI, Cortés A, Meiler J, Casadó V, Ferré S.

Mol Neurobiol. 2018 Nov;55(11):8438-8454. doi: 10.1007/s12035-018-1004-1. Epub 2018 Mar 18.

PMID:
29552726
32.

Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain.

Navarro G, Cordomí A, Brugarolas M, Moreno E, Aguinaga D, Pérez-Benito L, Ferre S, Cortés A, Casadó V, Mallol J, Canela EI, Lluís C, Pardo L, McCormick PJ, Franco R.

BMC Biol. 2018 Feb 28;16(1):24. doi: 10.1186/s12915-018-0491-x.

33.

Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor.

Yano H, Cai NS, Xu M, Verma RK, Rea W, Hoffman AF, Shi L, Javitch JA, Bonci A, Ferré S.

Nat Commun. 2018 Feb 5;9(1):486. doi: 10.1038/s41467-017-02606-w.

34.

Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Ferré S, Quiroz C, Guitart X, Rea W, Seyedian A, Moreno E, Casadó-Anguera V, Díaz-Ríos M, Casadó V, Clemens S, Allen RP, Earley CJ, García-Borreguero D.

Front Neurosci. 2018 Jan 8;11:722. doi: 10.3389/fnins.2017.00722. eCollection 2017.

35.

Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease.

Fernández-Dueñas V, Pérez-Arévalo A, Altafaj X, Ferré S, Ciruela F.

Front Neurosci. 2017 Nov 22;11:652. doi: 10.3389/fnins.2017.00652. eCollection 2017. No abstract available.

36.

Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

Yepes G, Guitart X, Rea W, Newman AH, Allen RP, Earley CJ, Quiroz C, Ferré S.

Ann Neurol. 2017 Dec;82(6):951-960. doi: 10.1002/ana.25104. Epub 2017 Dec 7.

37.

A strategic plan to identify key neurophysiological mechanisms and brain circuits in autism.

Bonnet-Brilhault F, Tuller L, Prévost P, Malvy J, Zebib R, Ferré S, Dos Santos C, Roux S, Houy-Durand E, Magné R, Mofid Y, Latinus M, Wardak C, Aguillon-Hernandez N, Batty M, Gomot M.

J Chem Neuroanat. 2018 Apr;89:69-72. doi: 10.1016/j.jchemneu.2017.11.007. Epub 2017 Nov 8. Review.

PMID:
29128349
38.

Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.

Ferrè S, Li X, Adams-Huet B, Maalouf NM, Sakhaee K, Toto RD, Moe OW, Neyra JA.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1389-1396. doi: 10.1093/ndt/gfx275.

39.

Bioluminescence Resonance Energy Transfer Assay to Characterize Gi-Like G Protein Subtype-Dependent Functional Selectivity.

Yano H, Sánchez-Soto M, Ferré S.

Curr Protoc Neurosci. 2017 Oct 23;81:5.33.1-5.33.13. doi: 10.1002/cpns.38.

40.

Behavioral control by striatal adenosine A2A -dopamine D2 receptor heteromers.

Taura J, Valle-León M, Sahlholm K, Watanabe M, Van Craenenbroeck K, Fernández-Dueñas V, Ferré S, Ciruela F.

Genes Brain Behav. 2018 Apr;17(4):e12432. doi: 10.1111/gbb.12432. Epub 2017 Nov 17.

PMID:
29053217
41.

Development of novel biosensors to study receptor-mediated activation of the G-protein α subunits Gs and Golf.

Yano H, Provasi D, Cai NS, Filizola M, Ferré S, Javitch JA.

J Biol Chem. 2017 Dec 8;292(49):19989-19998. doi: 10.1074/jbc.M117.800698. Epub 2017 Oct 17.

42.

Role of placebo effects in pain and neuropsychiatric disorders.

Belcher AM, Ferré S, Martinez PE, Colloca L.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):298-306. doi: 10.1016/j.pnpbp.2017.06.003. Epub 2017 Jun 14. Review.

PMID:
28595945
43.

Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders.

Ferré S.

Curr Treat Options Psychiatry. 2017;4(2):167-183. doi: 10.1007/s40501-017-0109-x. Epub 2017 Apr 22. Review.

44.

Beam shaping in high-power broad-area quantum cascade lasers using optical feedback.

Ferré S, Jumpertz L, Carras M, Ferreira R, Grillot F.

Sci Rep. 2017 Mar 13;7:44284. doi: 10.1038/srep44284.

45.

Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.

Guitart X, Chern Y, Ferré S.

Oncotarget. 2017 Feb 21;8(8):12550-12551. doi: 10.18632/oncotarget.15111. No abstract available.

46.

Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission.

Bonaventura J, Quiroz C, Cai NS, Rubinstein M, Tanda G, Ferré S.

Sci Adv. 2017 Jan 11;3(1):e1601631. doi: 10.1126/sciadv.1601631. eCollection 2017 Jan.

47.

Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.

Moreno E, Quiroz C, Rea W, Cai NS, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, Ferré S.

J Neurosci. 2017 Feb 1;37(5):1176-1186. doi: 10.1523/JNEUROSCI.2442-16.2016. Epub 2016 Dec 22.

48.

In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine.

Ferré S, Earley C, Gulyani S, Garcia-Borreguero D.

Sleep Med. 2017 Mar;31:86-92. doi: 10.1016/j.sleep.2016.08.019. Epub 2016 Nov 1. Review.

PMID:
27899234
49.

Specific subtype of fluency disorder affecting French speaking children: A phonological analysis.

Brejon Teitler N, Ferré S, Dailly C.

J Fluency Disord. 2016 Dec;50:33-43. doi: 10.1016/j.jfludis.2016.09.002. Epub 2016 Sep 11.

PMID:
27865228
50.

Comparative study of SiO<sub>2</sub>, Si<sub>3</sub>N<sub>4</sub> and TiO<sub>2</sub> thin films as passivation layers for quantum cascade lasers.

Ferré S, Peinado A, Garcia-Caurel E, Trinité V, Carras M, Ferreira R.

Opt Express. 2016 Oct 17;24(21):24032-24044. doi: 10.1364/OE.24.024032.

PMID:
27828235

Supplemental Content

Support Center